姓名:陳韻如  Yun-Ju Chen    科別:醫學研究部    論文篇數: 17


AuthorTitleSourceYear
Chen CH, Hsia TC, Yeh MH, Chen TW, Chen YJ, Chen JT, Wei YL, Tu CY, Huang WC.MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK-mediated HER2 phosphorylation at Thr701.Mol Oncol. 2017 Jun 20. doi: 10.1002/1878-0261.12102. [Epub ahead of print]2017
Chen JY, Chen YJ, Yen CJ, Chen WS, Huang WC.HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.Oncotarget. 2016 Jan 5;7(1):473-89. doi: 10.18632/oncotarget.6337.2016
Huang WC, Hung CM, Wei CT, Chen TM, Chien PH, Pan HL, Lin YM, Chen YJ.Interleukin-6 expression contributes to lapatinib resistance through maintenance of stemness property in HER2-positive breast cancer cells.Oncotarget. 2016 Sep 20;7(38):62352-62363. doi: 10.18632/oncotarget.11471.2016
Chen WS, Liu LC, Yen CJ, Chen YJ, Chen JY, Ho CY, Liu SH, Chen CC, Huang WC.Nuclear IKKα mediates microRNA-7/-103/107/21 inductions to downregulate maspin expression in response to HBx overexpression.Oncotarget. 2016 Jul 7. doi: 10.18632/oncotarget.10462. [Epub ahead of print]2016
Hsiao YC, Yeh MH, Chen YJ, Liu JF, Tang CH6, Huang WC.Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6.Oncotarget. 2015 Nov 10;6(35):37965-78. doi: 10.18632/oncotarget.5700.2015
Lin CW, Chen YS, Lin CC, Chen YJ, Lo GH, Lee PH, Kuo PL, Dai CY, Huang JF, Chung WL, Yu ML.Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy.Sci Rep. 2015 Oct 30;5:15807. doi: 10.1038/srep15807.2015
Chen WS, Yen CJ, Chen YJ, Chen JY, Wang LY, Chiu SJ, Shih WL, Ho CY, Wei TT, Pan HL, Chien PH, Hung MC, Chen CC, Huang WC.miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin.Oncotarget. 2015 Sep 22;6(28):25962-74. doi: 10.18632/oncotarget.4504.2015
Wu SJ, Chen YJ, Shieh TY, Chen CM, Wang YY, Lee KT, Lin YM, Chien PH, Chen PH.Association study between novel CYP26 polymorphisms and the risk of betel quid-related malignant oral disorders.ScientificWorldJournal. 2015;2015:160185. doi: 10.1155/2015/160185. Epub 2015 Mar 9.2015
Hsiao YC, Yeh MH, Chen YJ, Liu JF, Tang CH, Huang WC.Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6.Oncotarget. 2015 Nov 10;6(35):37965-78. doi: 10.18632/oncotarget.5700.2015
Wu SJ, Chen YJ, Shieh TY, Chen CM, Wang YY, Lee KT, Lin YM, Chien PH, Chen PH.Association Study between Novel CYP26 Polymorphisms and the Risk of Betel Quid-Related Malignant Oral Disorders.ScientificWorldJournal. 2015;2015:160185. doi: 10.1155/2015/160185. Epub 2015 Mar 9.2015
Hung CM, Huang WC, Pan HL, Chien PH, Lin CW, Chen LC, Chien YF, Lin CC, Leow KH, Chen WS, Chen JY, Ho CY, Hou PS, Chen YJ.Hepatitis B Virus X Upregulates HuR Protein Level to Stabilize HER2 Expression in Hepatocellular Carcinoma Cells.Biomed Res Int. 2014;2014:827415. doi: 10.1155/2014/827415. Epub 2014 Feb 27.2014
Tu CY, Chen CH, Hsia TC, Hsu MH, Wei YL, Yu MC, Chen WS, Hsu KW, Yeh MH, Liu LC, Chen YJ, Huang WC.Trichostatin A Suppresses EGFR Expression through Induction of MicroRNA-7 in an HDAC-Independent Manner in Lapatinib-Treated Cells.Biomed Res Int. 2014;2014:168949. doi: 10.1155/2014/168949. Epub 2014 Feb 23.2014
Chen YJ, Yeh MH, Yu MC, Wei YL, Chen WS, Chen JY, Shih CY, Tu CY, Chen CH, Hsia TC, Chien PH, Liu SH, Yu YL, Huang WC.Lapatinib--induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors.Breast Cancer Res. 2013 Nov 12;15(6):R108. [Epub ahead of print]2013
Chen YJ, Chien PH, Chen WS, Chien YF, Hsu YY, Wang LY, Chen JY, Lin CW, Huang TC, Yu YL, Huang WC.Hepatitis B Virus-Encoded X Protein Downregulates EGFR Expression via Inducing MicroRNA-7 in Hepatocellular Carcinoma Cells.Evid Based Complement Alternat Med. 2013;2013:682380. doi: 10.1155/2013/682380. Epub 2013 Jun 11.2013
Chen YJ, Chen HP, Cheng YJ, Lin YH, Liu KW, Chen YJ, Hou MF, Wu YC, Lee YC, Yuan SS.The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathway.Life Sci. 2013 Jun 13;92(22):1081-92. doi: 10.1016/j.lfs.2013.04.007. Epub 2013 Apr 26.2013
Chen YJ, Kay N, Yang JM, Lin CT, Chang HL, Wu YC, Fu CF, Chang Y, Lo S, Hou MF, Lee YC, Hsieh YC, Yuan SS.Total synthetic protoapigenone WYC02 inhibits cervical cancer cell proliferation and tumour growth through PIK3 signalling pathway.Basic Clin Pharmacol Toxicol. 2013 Jul;113(1):8-18. doi: 10.1111/bcpt.12057. Epub 2013 Mar 21.2013
Yuan SS, Hou MF, Hsieh YC, Huang CY, Lee YC, Chen YJ, Lo S.Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.J Natl Cancer Inst. 2012 Oct 3;104(19):1485-502. doi: 10.1093/jnci/djs355. Epub 2012 Aug 22.2012